Women’s Heart Health Expansion Act of 2026
- Sponsor
- Rep. Beatty, Joyce [D-OH-3]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Feb 9, 2026
Bottom line
This bill reauthorizes and funds a federal program aimed at improving cardiovascular health screenings and education for low-income women.
What it actually does
This bill reauthorizes the WISEWOMAN (Well-Integrated Screening and Evaluation for WOMen Across the Nation) program, which provides supplemental grants to states for preventive health services. These services include screenings for blood pressure and cholesterol, as well as health education, for low-income women. It expands eligibility to include other low-income women beyond those already receiving breast and cervical cancer screenings and authorizes $250 million for fiscal years 2027 through 2031.
Proponents argue
Supporters argue that the WISEWOMAN program is a critical public health initiative that effectively addresses preventable cardiovascular disease in underserved populations. They emphasize that early detection, health education, and appropriate referrals lead to better health outcomes, reduce health disparities, and can ultimately lower long-term healthcare costs for women at higher risk.
Opponents contend
Direct opposition to this specific public health program is generally rare due to its focus on preventive care. However, potential critics might raise concerns about the overall level of federal spending, question the efficiency of grant-based programs compared to other healthcare delivery models, or suggest that such services could be more effectively integrated into existing primary care infrastructure without additional federal authorization.
The bill is very short and uses clear language, making it highly accessible for a reader to understand its provisions quickly.
Section 2, amending Section 1509 of the Public Health Service Act
Reauthorization and Expansion of the WISEWOMAN Program
This section reauthorizes the WISEWOMAN program, which provides federal grants to states to offer preventive health services. These services include screenings for blood pressure and cholesterol, as well as health education, for low-income women. The bill expands eligibility to include not only women already receiving breast and cervical cancer screenings but also other low-income women who meet criteria set by the Secretary of Health and Human Services. It also authorizes $250,000,000 for the program for fiscal years 2027 through 2031.
Supporters argue
Supporters argue that reauthorizing WISEWOMAN is crucial for continuing to combat cardiovascular disease, which remains the leading cause of death for women, especially among low-income and minority populations who often face significant health disparities. They contend that early screening and health education are highly cost-effective ways to prevent more serious health issues and improve overall public health.
Critics contend
No specific opposition is typically raised against the reauthorization of this public health program, as its goals align with broad public health objectives of improving preventive care. General opposition might stem from broader concerns about federal spending or the scope of federal involvement in health services.
Tradeoffs
The primary tension involves balancing the need for targeted federal funding for specific public health initiatives against broader calls for healthcare system integration and efficiency. While effective, such programs require ongoing federal investment, which some might argue could be better addressed through comprehensive healthcare reforms or existing state-level programs.